692 results
Page 11 of 35
6-K
EX-99.1
1wynkzroghsma
22 Feb 13
Additional QNASL® (beclomethasone dipropionate) Nasal Aerosol Data to be Presented at Annual Allergy Meeting
12:00am
6-K
EX-99.1
vwh0a1wtvhbgdospfis4
14 Feb 13
Live Filing
12:00am
6-K
EX-99.1
k2w31c1pe8ylha r31
11 Feb 13
Teva Pharmaceuticals Announces Appointment of Dr. Arie Belldegrun to Board of Directors
12:00am
6-K
EX-99.1
btp42 pcfx2
7 Feb 13
Teva Reports Fourth Quarter and Full Year 2012 Results
12:00am
6-K
EX-99.1
mgfzlnl 03g8
5 Feb 13
Teva Announces First Patient Enrolled In Largest Clinical Study to Date Evaluating Azilect® for Mild Cognitive Impairment In Parkinson’s Disease
12:00am
6-K
EX-99.1
9bl1u7o3neuou4u
31 Jan 13
Teva Announces Termination of Agreements with Curetech
12:00am
6-K
EX-99.1
s9rvjxo ukplh9gp
23 Jan 13
Live Filing
12:00am
6-K
EX-99.1
q1tuc kl3qkazfh0tn5
18 Dec 12
Teva Signs New $3.0 Billion Syndicated Revolving Credit Facility
12:00am
6-K
EX-99.1
yr8nezl9wk3c 48l9ul
18 Dec 12
Live Filing
12:00am
6-K
EX-99.1
gk78ruqxb4qif
17 Dec 12
Teva Enters Agreement with Handok to Establish Business Venture with Significant Presence in Korean Pharmaceutical Market
12:00am
424B5
zjguyc jcpsusr0nx1
14 Dec 12
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
uazu2
14 Dec 12
Teva Announces Pricing of $2.0 Billion of Senior Notes
12:00am
6-K
EX-99.1
imy 2v6a3
13 Dec 12
Teva Receives A- Rating from Fitch Ratings with a Stable Outlook
12:00am
424B5
6plpny7q85cvag
13 Dec 12
Prospectus supplement for primary offering
12:00am
6-K
EX-99
m310n6y5zo w2wh8
11 Dec 12
Live Filing
12:00am
6-K
n6wad2vxq05memgkh2
5 Dec 12
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
1immbx9kqu xfx6cs7
30 Nov 12
Teva Pharmaceutical Industries Limited 6-K
12:00am
6-K
p2k0bvr
1 Nov 12
Current report (foreign)
12:00am
6-K
EX-99.1
ofzye59mzn52
1 Nov 12
Teva Reports Third Quarter 2012 Results
12:00am